These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2847932)

  • 1. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
    Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
    Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of B lymphocytes via CD72 (human Lyb-2).
    Kamal M; Katira A; Gordon J
    Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40).
    Cairns J; Flores-Romo L; Millsum MJ; Guy GR; Gillis S; Ledbetter JA; Gordon J
    Eur J Immunol; 1988 Mar; 18(3):349-53. PubMed ID: 2965643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
    Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
    Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
    Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
    J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
    Katira A; Kamal M; Gordon J
    Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
    Prinz JC; Baur X; Mazur G; Rieber EP
    Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-CD23 antibodies induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human activated B cells. Involvement of a Gp protein.
    Kolb JP; Renard D; Dugas B; Genot E; Petit-Koskas E; Sarfati M; Delespesse G; Poggioli J
    J Immunol; 1990 Jul; 145(2):429-37. PubMed ID: 2164062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human monocyte cell-surface and soluble CD23 (Fc epsilon RII) by granulocyte-macrophage colony-stimulating factor and IL-3.
    Alderson MR; Tough TW; Ziegler SF; Armitage RJ
    J Immunol; 1992 Aug; 149(4):1252-7. PubMed ID: 1386861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
    Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
    Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.
    Gordon J; Millsum MJ; Guy GR; Ledbetter JA
    J Immunol; 1988 Mar; 140(5):1425-30. PubMed ID: 3257976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
    Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
    J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
    Zhang K; Clark EA; Saxon A
    J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
    Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
    Gordon J; Katira A; Strain AJ; Gillis S
    Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
    Vazquez A; Mills S; Sharma S; Maizel AL
    Eur J Immunol; 1988 Oct; 18(10):1647-9. PubMed ID: 2973416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts.
    Cairns JA; Gordon J
    Eur J Immunol; 1990 Mar; 20(3):539-43. PubMed ID: 2138559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.